| Financial Year |
September 30 2022 |
| Monetary Funds |
5,557,802,542.81 |
| Held-for-trading Financial Assets |
1,715,135.21 |
| Notes Receivable |
1,408,497,088.94 |
| Accounts Receivable |
10,111,194,795.25 |
| Advances to Suppliers |
575,092,978.15 |
| Other Receivables |
141,158,709.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,819,289,413.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,139,584.02 |
| Total Current Assets |
25,057,034,420.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
297,167,446.38 |
| Investment Properties |
183,064,128.50 |
| Fixed Assetes |
5,678,965,824.07 |
| Under-construction Projects |
1,287,405,192.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,061,024,606.17 |
| R&D expenses |
148,536,686.65 |
| Goodwill |
311,565,698.69 |
| Long-Term Deferred and Prepaid Expenses |
11,275,724.42 |
| Deferred Income Tax Assets |
143,285,505.14 |
| Other Non-Current Assets |
587,560,225.22 |
| Sub-Total of Non-Current Assets |
10,918,771,008.98 |
| Total Assets |
35,975,805,429.41 |
| Short-Term Loans |
1,218,260,301.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,585,318,271.42 |
| Accounts Payable |
7,788,156,779.02 |
| Accounts Received In Advance |
41,185,292.18 |
| Employee Compensation Payable |
592,241,414.69 |
| Taxes Payable |
119,893,739.16 |
| Interest Payable |
877,000.00 |
| Dividend Payable |
27,586,326.27 |
| Other payables |
590,020,205.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,366,756,696.74 |
| Other Current Liabilities |
236,507,154.93 |
| Sub-Total of Current Liabilities |
16,712,281,261.56 |
| Long-term Loans |
526,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-2,152,371,022.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
39,014,966.99 |
| Deferred Income Tax Liabilities |
197,054,076.23 |
| Other Non-Current Liabilities |
1,842,322,052.68 |
| Sub-Total of Non-Current Liabilities |
1,443,126,242.07 |
| Total Liabilities |
18,155,407,503.63 |
| Paid-In Capital(Or Share Stock) |
3,884,824,789.00 |
| Capital Surplus |
2,738,743,170.73 |
| Surplus Reserve |
690,599,663.79 |
| LESS:Treasury Stock |
154,893,610.43 |
| Undistributed Profits |
6,855,069,966.64 |
| Minority Stockholder's Interest |
3,288,439,628.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,531,958,297.50 |
| Owner's Equity（Stockholder's Equity） |
17,820,397,925.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,975,805,429.41 |
